Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kamran Alam Insider Profile
4 Followers
Kamran Alam, CFO, VP Finance at Neurogene, holds 0.00 shares in Neurogene (Ticker: NGNE). Most recently, Kamran Alam Sold $29,079 shares of Neurogene on Aug 14, 2015 for an estimated value of 542.90K.
Kamran Alam has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Kamran Alam does not currently own shares as a corporate insider.
A breakdown of Kamran Alam's holdings
Insider Roles
CFO, VP Finance
Roles that Kamran Alam holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Kamran Alam
Kamran Alam's Trading History
List of latest transactions for each holding click on a transaction to see Kamran Alam's performance on stock
You May Also Like
Kamran Alam insider profile FAQ
What is the percentage of profitable transactions made by Kamran Alam?
The percentage of profitable transactions made by Kamran Alam is ―.
What is the average return per transaction made by Kamran Alam?
The average return per transaction made by Kamran Alam is ―.
What stocks does Kamran Alam hold?
Kamran Alam holds: NGNE stocks.
What was Kamran Alam’s latest transaction?
Kamran Alam latest transaction was an Informative Sell of $542.90K.
What was Kamran Alam's most profitable transaction?
Kamran Alam’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kamran Alam's role in Neurogene?
Kamran Alam's role in Neurogene is CFO, VP Finance.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.